Prognostic value of electroencephalography in Reye's syndrome.
D000273:Adipose Tissue; D000293:Adolescent; D000641:Ammonia / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000378:metabolism; D001786:Blood Glucose / Q000032:analysis; D001927:Brain Diseases / Q000175:diagnosis*; D002648:Child; D002675:Child, Preschool; D003243:Consciousness; D004569:Electroencephalography; D005234:Fatty Liver; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006505:Hepatitis / Q000150:complications*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007427:Intracranial Pressure; D007674:Kidney Diseases; D008297:Male; D011379:Prognosis; D012640:Seizures / Q000209:etiology; D014812:Vitamin K / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D001786:Blood Glucose; D005938:Glucocorticoids; D007328:Insulin; D014812:Vitamin K; D000641:Ammonia; D001219:Aspartate Aminotransferases; D005947:Glucose